
News from enn.com
Top enn.com News

PharmaA new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously resisted treatment.See the Story
New drug-releasing system eliminates tumors in 82% of high-risk bladder cancer patients
67% Center coverage: 3 sources